Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 3/20 | 1.00 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 1.00 |
| ▸ | LDHB | P07195 | 3/20 | 0.43 |
| ▸ | TERF2IP | Q9NYB0 | 4/20 | 0.42 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.39 |
| ▸ | NPY1R | P25929 | 1/20 | 0.39 |
| ▸ | NPY2R | P49146 | 1/20 | 0.39 |
| ▸ | NPY4R | P50391 | 1/20 | 0.39 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.39 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.39 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.39 |
| ▸ | SSTR2 | P30874 | 3/20 | 0.39 |
| ▸ | SSTR4 | P31391 | 3/20 | 0.39 |
| ▸ | SSTR5 | P35346 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27013344 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL136097 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL18902502 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL14241069 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL7799155 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL16549195 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL23626629 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL15507051 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| SCHEMBL21991628 | 1.00 | KDM1A (1.00) | KDM1ARCOR1LDHBTERF2IPEGFR | |
| Polymyxin B2 SCHEMBL29514784 | 0.99 | KDM1A (0.98) | KDM1ARCOR1LDHBTERF2IPEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250290057-A1 | LYTIC AGENT FOR ENTEROCOCCUS FAECALIS | THE UNIVERSITY OF TOKYO (JP) | 2025-09-18 | — | — | US | disclosed |
| US-20250275983-A1 | D2O STABILIZED PHARMACEUTICAL FORMULATIONS | Sydnexis, Inc. | 2025-09-04 | — | — | US | disclosed |
| EP-4590283-A1 | MUCOADHESIVE DRUG DELIVERY SYSTEMS AND METHODS OF USE | Madd Ophthalmics Ltd. (CA) | 2025-07-30 | — | — | EP | disclosed |
| EP-4516310-A1 | BACTERIOLYTIC AGENT AGAINST ENTEROCOCCUS FAECALIS | The University of Tokyo (JP) | 2025-03-05 | — | — | EP | disclosed |
| CN-119306821-A | Antibody against rabies virus and use thereof | 广州汉腾生物科技有限公司 | 2025-01-14 | — | — | CN | disclosed |
| US-20250000895-A1 | POLYMERS OBTAINED BY THE REACTION OF A PHENOLIC COMPOUND AND A CARBONYL COMPOUND FOR USE IN THE TREATMENT OR PREVENTION OF A CONDITION ASSOCIATED WITH ONE OR MORE PROTEASE(S) | BASF SE (DE) | 2025-01-02 | — | — | US | disclosed |
| WO-2024217576-A1 | FUSION POLYPEPTIDE AND KIT FOR DETECTING PROCALCITONIN AND USE THEREOF | 深圳琅技生命科技有限公司 | 2024-10-24 | — | — | WO | disclosed |
| WO-2024217577-A1 | PEPTIDE AND LUMINESCENT COMPLEX CONTAINING SAME | 深圳琅技生命科技有限公司 | 2024-10-24 | — | — | WO | disclosed |
| US-20240277787-A1 | USE OF LACTOBACILLUS FERMENTUM STRAIN AND NATURAL KILLER CELLS FOR COMBINATION THERAPY FOR PREVENTION OR TREATMENT OF METABOLIC DISEASES | GI CELL, INC. (KR) | 2024-08-22 | — | — | US | disclosed |
| WO-2024167277-A1 | COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER USING COMBINED THERAPY OF LACTOBACILLUS PLANTARUM STRAIN AND IMMUNE CELLS | 주식회사 지아이바이옴 | 2024-08-15 | — | — | WO | disclosed |
| WO-2024059952-A1 | MUCOADHESIVE DRUG DELIVERY SYSTEMS AND METHODS OF USE | MADD OPHTHALMICS LTD. (CA) | 2024-03-28 | — | — | WO | disclosed |
| WO-2023051925-A1 | POLYMERS OBTAINED BY THE REACTION OF A PHENOLIC COMPOUND AND A CARBONYL COMPOUND FOR USE IN THE TREATMENT OR PREVENTION OF A CONDITION ASSOCIATED WITH ONE OR MORE PROTEASE(S) | BASF SE (DE) | 2023-04-06 | — | — | WO | disclosed |
| WO-2023052520-A1 | POLYMERS OBTAINED BY THE REACTION OF A PHENOLIC COMPOUND AND A CARBONYL COMPOUND FOR USE IN THE TREATMENT OR PREVENTION OF A CONDITION ASSOCIATED WITH ONE OR MORE PROTEASE(S) | BASF SE (DE) | 2023-04-06 | — | — | WO | disclosed |
| CN-111334291-B | Aggregation-induced emission fluorescence turn-on probe and preparation method and application thereof | 天津市口腔医院 | 2023-02-28 | — | — | CN | disclosed |
| US-20230014358-A1 | COMPOSITION FOR ANTICANCER TREATMENT, COMPRISING NK CELLS AND FUSION PROTEIN WHICH COMPRISES IL-2 PROTEIN AND CD80 PROTEIN | GI INNOVATION, INC. (KR) | 2023-01-19 | — | — | US | disclosed |
| WO-2022240240-A1 | COMPOSITION FOR NK CELL CRYOPRESERVATION, AND CRYOPRESERVATION FORMULATION COMPRISING SAME | 주식회사 지아이셀 | 2022-11-17 | — | — | WO | disclosed |
| EP-4067481-A1 | COMPOSITION FOR ANTICANCER TREATMENT, COMPRISING NK CELLS AND FUSION PROTEIN WHICH COMPRISES IL-2 PROTEIN AND CD80 PROTEIN | GI Cell, Inc. (KR) | 2022-10-05 | — | — | EP | disclosed |
| CN-215664635-U | ARGs absolute quantitative kit suitable for 96-channel qPCR instrument | 合肥元哉生物科技有限公司 | 2022-01-28 | — | — | CN | disclosed |
| WO-2017189868-A1 | SERINE REPLACEMENT POLYMYXIN ANALOGUES USEFUL AS ANTIBIOTIC POTENTIATORS | SPERO OPCO (US) | 2017-11-02 | — | — | WO | disclosed |
| WO-2017189866-A1 | POLYMYXIN ANALOGS USEFUL AS ANTIBIOTIC POTENTIATORS | SPERO OPCO (US) | 2017-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000895-A1 | POLYMERS OBTAINED BY THE REACTION OF A PHENOLIC COMPOUND AND A CARBONYL COMPOUND FOR USE IN THE TREATMENT OR PREVENTION OF A CONDITION ASSOCIATED WITH ONE OR MORE PROTEASE(S) | CTRL, PRSS2, CTSS | KDM1A 672/4885RCOR1 2224/4885LDHB 974/4885 |
| US-20250275983-A1 | D2O STABILIZED PHARMACEUTICAL FORMULATIONS | AQP1, AQP3, CRYZ | KDM1A 2952/4885RCOR1 4414/4885LDHB 2349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.